InspireMD, Inc. Proceeds from Issuance or Sale of Equity
InspireMD, Inc. (NSPR) reported Proceeds from Issuance or Sale of Equity of $16.85 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-12.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOrSaleOfEquity · last filed 2025-03-12
- InspireMD, Inc. proceeds from issuance or sale of equity for the quarter ending 2024-12-31 was $0.00.
- InspireMD, Inc. proceeds from issuance or sale of equity for the quarter ending 2023-12-31 was $0.00.
- InspireMD, Inc. proceeds from issuance or sale of equity for the quarter ending 2023-09-30 was $0.00.
- InspireMD, Inc. proceeds from issuance or sale of equity for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- InspireMD, Inc. proceeds from issuance or sale of equity for fiscal 2024 was $16.85M, a 55.10% decline from fiscal 2023.
- InspireMD, Inc. proceeds from issuance or sale of equity for fiscal 2023 was $37.53M.
- InspireMD, Inc. proceeds from issuance or sale of equity for fiscal 2021 was $35.03M, a 113.69% increase from fiscal 2020.
- InspireMD, Inc. proceeds from issuance or sale of equity for fiscal 2020 was $16.39M.
| Period end | Proceeds from Issuance or Sale of Equity 0 month | Proceeds from Issuance or Sale of Equity 3 month | Proceeds from Issuance or Sale of Equity 6 month | Proceeds from Issuance or Sale of Equity 9 month | Proceeds from Issuance or Sale of Equity 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $16.85M 10-K · filed 2025-03-12 | |||
| 2024-09-30 | $16.85M 10-Q · filed 2024-11-12 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $37.53M 10-K · filed 2024-03-05 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $37.53M 10-Q · filed 2023-11-06 | |||
| 2023-06-30 | $37.53M 10-Q · filed 2024-08-05 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$35.00K derived: sum of 2 quarters · filed 2023-03-30 | -$34.00K derived: sum of 3 quarters · filed 2023-03-30 | $35.03M 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$34.00K derived: sum of 2 quarters · filed 2022-11-07 | $35.03M 10-Q · filed 2022-11-07 | $39.10M derived: sum of 4 quarters · filed 2022-11-07 | |
| 2021-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $35.07M 10-Q · filed 2022-08-08 | $39.14M derived: sum of 3 quarters · filed 2022-08-08 | $39.23M derived: sum of 4 quarters · filed 2022-08-08 | |
| 2021-03-31 | $35.07M 10-Q · filed 2022-05-09 | $39.14M derived: sum of 2 quarters · filed 2022-05-09 | $39.23M derived: sum of 3 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $4.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $4.16M derived: sum of 2 quarters · filed 2022-03-07 | $16.39M 10-K · filed 2022-03-07 | ||
| 2020-09-30 | $90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $12.33M 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | $12.24M 10-Q · filed 2021-08-09 | ||||
| 2016-03-21 | $1.40M 10-K · filed 2018-02-13 | ||||
| 2015-03-09 | $12.40M 10-K · filed 2017-02-16 | ||||
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-07 | $617.00K derived: sum of 2 quarters · filed 2013-05-07 | $1.05M 10-Q · filed 2013-05-07 | ||
| 2012-12-31 | $617.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-04 | $1.05M 10-Q · filed 2013-02-04 | |||
| 2012-09-30 | $432.00K 10-Q · filed 2013-11-12 | ||||
| 2012-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-07 | $0.00 derived: sum of 2 quarters · filed 2013-05-07 | $1.50M 10-Q · filed 2013-05-07 | ||
| 2011-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-04 | $1.50M 10-Q · filed 2013-02-04 | |||
| 2011-09-30 | $1.50M 10-Q · filed 2012-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |